J-COMPASS study(long term study by MPI and CT)

J-COMPASS study(long term study by MPI and CT) - J-COMPASS study(long term study by MPI and CT)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019567

Enrollment

1300

Registered

2015-10-30

Start date

2015-06-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.MPI group or CT group 2.Facilities which can cooperate with a investigation 3.Case who did not reject

Exclusion criteria

Exclusion criteria: 1.In primary case who had already J-COMPASS study study,had cardiovascular death. 2.Case who investigator judged as ineligible for this study

Design outcomes

Primary

Measure	Time frame
Statistical comparisons of the three groups were based on a time-to-first-event analysis. The primary end-point was the occurrence of a major adverse cardiac event (MACE): cardiac death (sudden death, fatal acute myocardial infarction [MI], death for complication of cardiovascular procedures, fatal heart failure, or fatal stroke), hospitalization for major cardiac event (congestive heart failure, unstable angina, non-fatal MI, or late [>90 days] revascularization). Secondary end-point was included: all-cause death, revascularization therapy, non-fetal MI, readmission for heart failure, readmission for angina, cerebral bleeding, cerebral infarction, bleeding event.	—

Measure

Time frame

Statistical comparisons of the three groups were based on a time-to-first-event analysis. The primary end-point was the occurrence of a major adverse cardiac event (MACE): cardiac death (sudden death, fatal acute myocardial infarction [MI], death for complication of cardiovascular procedures, fatal heart failure, or fatal stroke), hospitalization for major cardiac event (congestive heart failure, unstable angina, non-fatal MI, or late [>90 days] revascularization). Secondary end-point was included: all-cause death, revascularization therapy, non-fetal MI, readmission for heart failure, readmission for angina, cerebral bleeding, cerebral infarction, bleeding event.

—

Countries

Japan

Contacts

Public ContactEriko Suzuki

Hokkaido University Nuclear medicine

ersuzuki@med.hokudai.ac.jp011-706-5152

Outcome results